TROY, MI
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)MICHIGAN SOCIETY OF HEMATOLOGY & ONCOLOGY, founded in 1985, is a community nonprofit that reported $1.4M in total revenue in fiscal year 2024. Revenue grew 11% year-over-year, indicating healthy expansion. The organization ran a surplus of $552K, a strong 41% operating margin.
THE ORGANIZATION'S MISSION IS TO PROMOTE EQUITABLE AND HIGH-QUALITY CARE FOR PATIENTS WITH CANCER AND BLOOD DISORDERS THROUGH ADVOCACY, EDUCATION AND RESEARCH.
MSHO CONDUCTED CONTINUING MEDICAL EDUCATION SEMINARS FOR PHYSICIAN MEMBERS. THESE SEMINARS WERE TO FURTHER ENHANCE THE SKILLSETS OF THE MEMBER PHYSICIANS. 3 SEMINARS WERE HELD WITH A COMBINED 610...
MSHO CONDUCTED CONTINUING MEDICAL EDUCATION SEMINARS FOR PHYSICIAN MEMBERS. THESE SEMINARS WERE TO FURTHER ENHANCE THE SKILLSETS OF THE MEMBER PHYSICIANS. 3 SEMINARS WERE HELD WITH A COMBINED 610 MEMBERS IN ATTENDANCE. ANNUAL REVIEW IN HEMATOLOGY AND ONCOLOGY AND AN UPDATE OCCURRED.
MSHO CONDUCTED CONTINUING EDUCATION SEMINARS FOR MEMBER NURSES AND ADVANCED PRACTICE PROVIDERS. THESE SEMINARS WERE TO FURTHER ENHANCE THEIR SKILLSETS AND PROVIDE REVIEW FOR OCN CERTIFICATION. 336...
MSHO CONDUCTED CONTINUING EDUCATION SEMINARS FOR MEMBER NURSES AND ADVANCED PRACTICE PROVIDERS. THESE SEMINARS WERE TO FURTHER ENHANCE THEIR SKILLSETS AND PROVIDE REVIEW FOR OCN CERTIFICATION. 336 WERE IN ATTENDANCE.
MSHO CONDUCTED SEMINARS FOR ADMINISTRATORS AND REIMBURSEMENT SPECIALISTS TO FURTHER ENHANCE THE SKILLSETS OF THE MEMBER BILLERS AND CODERS THROUGH CONTINUING EDUCATION. 797 WERE IN ATTENDANCE
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $1,359,386 | $1,220,188 | +0.1% |
| Expenses | $807,768 | $751,026 | +0.1% |
| Net Income | $551,618 | $469,162 | +0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ANAS AL-JANADI MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| TIMOTHY COX MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| THOMAS GRIBBIN MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| JOANN HIRTH MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| ANDREW MUSKOVITZ MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| CAROL RAPSON MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| OSCAR SIGNORI MD FACP | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| MICHAEL STENDER MD | TREASURER | N/A |
Officer
|
$0 | $0 | $0 |
| JEROME SEID MD FACP | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| MOHAMMED OGAILY MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| ZACHARY HECTOR-WORD MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| PHILIP KURIAKOSE MD FACP | PRESIDENT | N/A |
Director
|
$0 | $0 | $0 |
| ULKA VAISHAMPAYAN MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| DANIEL ISAAC DO | PRESIDENT EL | N/A |
Director
|
$0 | $0 | $0 |
| MARY KAY MAKAREWICZ | E. DIRECTOR/ | N/A |
Officer
|
$0 | $0 | $0 |
| YELENA KIER DO | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| SHRUTI JOLLY MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| MOHAMMAD OMAIRA MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| PHILIP PHILIP MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| AMMAR SUKARI MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| MACKENZIE MAYO MD | FELLOW | N/A |
Director
|
$0 | $0 | $0 |
| HIRVA MAMDANI MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| MARKIE ZIMMER MD | FELLOW | N/A |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $1,359,386 | $807,768 | $5,186,929 | $551,618 |
| 2023 | $1,220,188 | $751,026 | $4,375,630 | $469,162 |
| 2022 | $1,134,631 | $744,602 | $3,608,293 | $390,029 |
| 2021 | $1,023,674 | $663,094 | $3,631,868 | $360,580 |
| 2020 | $969,738 | $600,979 | $3,194,464 | $368,759 |
| 2019 | $887,030 | $643,969 | $2,570,423 | $243,061 |
| 2018 | $658,950 | $602,349 | $2,247,792 | $56,601 |
Compare MICHIGAN SOCIETY OF HEMATOLOGY & ONCOLOGY with other nonprofits in Michigan and across the country.